Literature DB >> 7816899

Synthesis of some new 1,6-dihydro-3-substituted 6-spiro-(9'-fluorene)-1,2,4-triazin-5-(4H)-ones as potential anti HIV and anticancer drugs.

R M Abdel-Rahman1, M Seada, M Fawzy, I el-Baz.   

Abstract

1,6-Dihydro-3(2H)-thioxo-6-spiro-(9'-fluorene)-1,2,4-triazin -5(4H)-one (1) has been used to synthesize several analogous compounds via nucleophilic substitution reactions. Spectroscopic data are given in support of the proposed structures. Some of the new products possessed good anti HIV and anticancer activities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816899

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  An efficient and facile synthesis of new tetracyclic fused pyrazolo[4,3-c][1,2,4]triazino[4,5-a]quinolin-4(5H)-ones.

Authors:  Mohsen A-M Gomaa; Huda A Ali
Journal:  Mol Divers       Date:  2018-07-03       Impact factor: 2.943

2.  The influence of substituents on the reactivity and cytotoxicity of imidazothiazolotriazinones.

Authors:  Galina A Gazieva; Alexei N Izmest'ev; Lada V Anikina; Sergey A Pukhov; Marina E Meshchaneva; Dmitry V Khakimov; Natalya G Kolotyrkina; Angelina N Kravchenko
Journal:  Mol Divers       Date:  2018-03-14       Impact factor: 2.943

3.  An effective one-pot access to polynuclear dispiroheterocyclic structures comprising pyrrolidinyloxindole and imidazothiazolotriazine moieties via a 1,3-dipolar cycloaddition strategy.

Authors:  Alexei N Izmest'ev; Galina A Gazieva; Natalya V Sigay; Sergei A Serkov; Valentina A Karnoukhova; Vadim V Kachala; Alexander S Shashkov; Igor E Zanin; Angelina N Kravchenko; Nina N Makhova
Journal:  Beilstein J Org Chem       Date:  2016-10-24       Impact factor: 2.883

4.  Synthesis and anticancer evaluation of some novel pyrimido[5,4-e][1,2,4]triazines and pyrazolo[3,4-d]pyrimidine using DMF-DMA as methylating and cyclizing agent.

Authors:  Samar A El-Kalyoubi
Journal:  Chem Cent J       Date:  2018-05-23       Impact factor: 4.215

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.